IntegriChain, a leading Life Sciences data and managed services company that helps drive access to life-saving and life-changing medicines, announced Monday that it has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. With this acquisition, IntegriChain delivers the Life Science industry’s most comprehensive and scalable data and business process platform for commercialization and market access of cell and gene therapy, specialty, and retail pharmaceuticals. This acquisition is IntegriChain’s fourth expansion since entering its strategic partnership with Accel-KKR, a leading technology focused private equity firm, in 2016.
Read the full article: IntegriChain Acquires the Life Sciences Division of Cumberland //
Source: https://www.prnewswire.com/news-releases/integrichain-acquires-the-life-sciences-division-of-cumberland-creating-the-largest-data-and-business-process-platform-for-market-access-and-commercialization-of-specialty-precision-and-retail-pharmaceuticals-301039090.html